First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma

Hillman Cancer Center, Pittsburgh

Medical University of South Carolina, Charleston

Clinica Universidad de Navarra, Pamplona

H. Lee Moffitt Cancer Center and Research Institute, Tampa

The Cleveland Clinic Foundation, Cleveland

University of Michigan, Ann Arbor

Barbara Ann Karmanos Cancer Institute, Detroit

University of Iowa Hospital and Clinics, Iowa City

University of Nebraska Medical Center, Omaha

Ochsner Medical Center, New Orleans

UT Southwestern, Dallas

MD Anderson Cancer Center, Houston

Colorado Blood Cancer Institute, Denver

Arizona Mayo Clinic, Phoenix

University of California at San Francisco, San Francisco

OHSU Knight Cancer Institute, Portland

Hackensack Meridian Health, Hackensack

Rhode Island Hospital, Providence

Monash Health, Clayton

Concord Hospital, Concord

St. Vincent Hospital, Fitzroy

Royal Brisbane and Women's Hospital, Herston

Royal Hobart Hospital RHH, Hobart

St. George Hospital, Kogarah

Cabrini Hospital, Malvern

Sir Charles Gairdner Hospital, Nedlands

Gold Coast Hospital, Southport

Westmead Hospital, Sydney

Tom Baker Cancer Care, Calgary

Toronto-Sunnybrook Regional Cancer Ctr, Toronto

Rigshospitalet, Copenhagen

Vejle Hospital, Vejle

Helsinki University Hospital, Helsinki

Kuopio University Hospital, Kuopio

Tampere University Hospital, Tampere

Hopital Henri Mondor, Créteil

CHU Montpellier, Montpellier

Hospital Saint-Louis, Paris

Hospices Civils de Lyon Centre Hospitalier Lyon Sud, Pierre-Bénite

Centre Henri Becquerel, Rouen

CHU de Tours-Hopital Bretonneau, Tours

Charite - Universitaetsmedizin Berlin, Berlin

Klinik fur Innere Medizin Hamatologie and Onkologie, Berlin

Universitaetsklinikum Koeln, Cologne

Universitaetsklinikum Essen, Essen

Johannes Gutenberg University, Mainz

Der Universität Munchen Medizinische Klinik III LMU, München

Ao Ss Antonio E Biagio Alessandria, Alessandria

Policlinico S. Orsola-Ematologia LA Seragnoli, Bologna

Istituto di Candiolo- Fondazione del Piemonte per l'Oncologia, Candiolo

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola

IRCCS Ospedale San Raffaele, Milan

VU University Medical Center, Amsterdam

Erasmus MC Cancer Institute, Rotterdam

Universitair Medisch Centrum Utrecht, Utrecht

Szpital Uniwersytecki nr 2 im dr. Jana Biziela, Bydgoszcz

Uniwersyteckie Centrum Kliniczne, Gdansk

Pratia-McM, Krakow

Wojewodzki Szpital Specjalistyczny im. Janusza Korczaka, Słupsk

Maria Sklodowska-Curie Memorial Cancer Center and Institute, Warsaw

Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego, Wroclaw

National University Hospital, Singapore

Singapore General Hospital, Singapore

Dong-A University Hospital, Busan

Keimyung University Dongsan Medical Center, Daegu

National Cancer Center, Goyang-si

Chonbuk National University Hospital, Jeonju

Seoul National University Bundang Hospital, Seongnam-si

Asan Medical Center, Seoul

Samsung Medical Center, Seoul

Seoul National University Hospital, Seoul

Severance Hospital, Yonsei University, Seoul

Hospital Germans Trias i Pujol, Badalona

Hospital Universitario Vall dHebron, Barcelona

Institut Catala de Oncologia, Barcelona

Hospital Universitario Fundacin Jimnez Daz, Madrid

Skåne University Hospital, Lund

Karolinska University Hospital Huddinge, Stockholm

Akademiska sjukhuset Uppsala University Hospital, Uppsala

The Christie NHS Foundation Trust, Manchester

Plymouth University School of Medicine- Derriford Hospital, Plymouth

University Hospital Southampton NHS Foundation Trust, Southampton

Royal Marsden NHS Foundation Trust, Sutton

Odense University Hospital, Odense

Maastricht University Medical Center, Maastricht